All Specimens Excluding Surveillance (% Susceptible)
Gram Negative Organisms | Year | Number of Isolates | Ampicillin | Ceftriaxone | Ceftazidime | Piperacillin- Tazobactam | Ertapenem | Meropenem | Gentamicin | Tobramycin | Amikacin | TMP/SMX | Ciprofloxacin | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HGH | E. coli | 2017 | 951 | 54 | 88 | – | 93 | 100 | 100 | 90 | 89 | 99 | 76 | 76 |
HGH | E. coli | 2016 | 1006 | 53 | 89 | – | 93 | 100 | 100 | 92 | 92 | 100 | 76 | 79 |
HGH | E. coli | 2014 | 1005 | 57 | 91 | – | 94 | 100 | 100 | 93 | 93 | 100 | 79 | 78 |
JCC | E. coli | 2017 | 965 | 52 | 87 | – | 94 | 100 | 100 | 90 | 89 | 100 | 76 | 76 |
JCC | E. coli | 2016 | 1008 | 51 | 87 | – | 93 | 100 | 100 | 91 | 91 | 100 | 76 | 76 |
CC | E. coli | 2014 | 1019 | 53 | 91 | – | 94 | 100 | 100 | 90 | 90 | 100 | 77 | 76 |
MUMC | E. coli | 2017 | 557 | 54 | 91 | – | 96 | 100 | 100 | 92 | 93 | 100 | 76 | 91 |
MUMC | E. coli | 2016 | 537 | 50 | 94 | – | 93 | 100 | 100 | 91 | 92 | 100 | 73 | 93 |
MUMC | E. coli | 2014 | 499 | 54 | 94 | – | 96 | 100 | 100 | 93 | 92 | 100 | 75 | 90 |
St. Joseph’s | E. coli | 2017 | 2321 | 56 | 91 | – | 95 | 100 | 100 | 92 | 92 | 100 | 77 | 81 |
St. Joseph’s | E. coli | 2016 | 2206 | 57 | 93 | – | 94 | 100 | 100 | 93 | 93 | 100 | 78 | 82 |
St. Joseph’s | E. coli | 2014 | 2225 | 58 | 92 | – | 96 | 100 | 100 | 93 | 93 | 100 | 79 | 82 |
HGH | Pseudomonas aeruginosa | 2017 | 276 | – | – | 85 | 89 | – | 88 | 91 | 98 | 99 | – | 83 |
HGH | Pseudomonas aeruginosa | 2016 | 248 | – | – | 88 | 93 | – | 89 | 92 | 98 | 98 | – | 82 |
HGH | Pseudomonas aeruginosa | 2014 | 188 | – | – | 87 | 94 | – | 90 | 93 | 97 | 99 | – | 85 |
JCC | Pseudomonas aeruginosa | 2017 | 201 | – | – | 88 | 93 | – | 93 | 96 | 99 | 100 | – | 88 |
JCC | Pseudomonas aeruginosa | 2016 | 173 | – | – | 89 | 91 | – | 89 | 97 | 99 | 99 | – | 87 |
JCC | Pseudomonas aeruginosa | 2014 | 156 | – | – | 89 | 92 | – | 93 | 94 | 99 | 100 | – | 86 |
MUMC | Pseudomonas aeruginosa | 2017 | 133 | – | – | 97 | 99 | – | 98 | 83 | 88 | 86 | – | 89 |
MUMC | Pseudomonas aeruginosa | 2016 | 134 | – | – | 97 | 98 | – | 94 | 74 | 83 | 78 | – | 87 |
MUMC | Pseudomonas aeruginosa | 2014 | 126 | – | – | 94 | 96 | – | 94 | 84 | 90 | 87 | – | 94 |
St. Joseph’s | Pseudomonas aeruginosa | 2017 | 290 | – | – | 88 | 93 | – | 96 | 91 | 98 | 98 | – | 84 |
St. Joseph’s | Pseudomonas aeruginosa | 2016 | 266 | – | – | 88 | 92 | – | 92 | 93 | 98 | 99 | – | 82 |
St. Joseph’s | Pseudomonas aeruginosa | 2014 | 224 | – | – | 92 | 94 | – | 96 | 96 | 98 | 99 | – | 84 |
Multi Drug Resistant Organisms (% Frequency)
(MRSA/All S aureus, VRE/All Enterococcus)
MRSA
Site | Year | All Spec Exc Surv | Blood Cultures |
---|---|---|---|
HGH | 2017 | 28% | 36% |
HGH | 2016 | 26% | 30% |
HGH | 2014 | 28% | No Data |
JCC | 2017 | 30% | 27% |
JCC | 2016 | 28% | 35% |
JCC | 2014 | 22% | No Data |
MUMC | 2017 | 15% | 11% |
MUMC | 2016 | 16% | 10% |
MUMC | 2014 | 15% | No Data |
StJ | 2017 | 31% | 26% |
StJ | 2016 | 31% | 33% |
StJ | 2014 | 30% | 33% |
VRE
Site | Year | All Spec Exc Surv | Blood Cultures |
---|---|---|---|
HGH | 2017 | 5% | 10.5% |
HGH | 2016 | 5% | 6% |
HGH | 2014 | 11% | No Data |
JCC | 2017 | 3% | 4.7% |
JCC | 2016 | 5% | 8.1% |
JCC | 2014 | 17% | No Data |
MUMC | 2017 | 1% | Insuff # |
MUMC | 2016 | 1% | Insuff # |
MUMC | 2014 | 4% | No Data |
StJ | 2017 | 5% | 11% |
StJ | 2016 | 2% | 3% |
StJ | 2014 | 2% | 6% |